personalized medicine News
Most Popular personalized medicine Story
Quintiles helps form personalized medicine joint venture
Stepping into the realm of personalized medicine, Quintiles ($QTRN) has created Oxford Cancer Biomarkers, a company focusing on the discovery and development of new cancer biomarkers, and on creating Read more...
Latest Headlines
Quintiles helps form personalized medicine joint venture
Stepping into the realm of personalized medicine, Quintiles ($QTRN) has created Oxford Cancer Biomarkers, a company focusing on the discovery and development of new cancer biomarkers, and on creating Read more...
Biomarkers provide route to personalized medicine
Personalized medicine--the ability to target drugs to specific patients as well as to specific diseases--is a major goal for drug development, from a number of different perspectives. For patients, Read more...
OncoSec, Serametrix team on skin cancer biomarkers
Personalized medicine allows physicians or researchers to select the patients who are most likely to respond to a treatment, improving patients' outcomes and speeding drug development. Under a Read more...
UPDATED: Dana-Farber, Brigham and Women's further personalized medicine via cancer genome database
The Dana-Farber Cancer Institute and Brigham and Women's Hospital have taken on a seemingly Herculean task with their new genomic database, called Profile. By compiling genetic data on nearly every Read more...
Canada focuses on biomarkers on road to personalized medicine
The website of the Canadian Institutes of Health Research (CIHR) is running a feature on the importance of biomarkers in our march toward personalized medicine. It begins with a fact that we are all Read more...
Quintiles, LGL pair to offer pharmacogenetics solutions
Quintiles has inked a non-exclusive deal with London Genetics Limited to offer the pharmaceutical industry pharmacogenetics solutions to advance personalized medicine. Financial terms of the deal Read more...
Biomarkers help drive growth of personalized med programs
That personalized medicine trend you've been hearing so much about isn't just a bunch of hype. A new study from the Tufts Center for the Study of Drug Development concludes that the personalized drug Read more...
Medco probes usefulness of markers for antipsychotics
The Medco Research Institute, the R&D arm of the giant pharmaceutical benefit manager, is mounting a clinical trial of a set of biomarkers from SureGene to determine whether variations in the Read more...
Roche licenses key cancer biomarker from Qiagen
Swiss pharma powerhouse Roche has inked a co-exclusive license on Qiagen's PI3K (phosphoinositide 3-kinase) biomarker so it can proceed with the development of new diagnostic assays. Johns Hopkins Read more...
